These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12826268)

  • 1. YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway.
    Hsu HK; Juan SH; Ho PY; Liang YC; Lin CH; Teng CM; Lee WS
    Biochem Pharmacol; 2003 Jul; 66(2):263-71. PubMed ID: 12826268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferation effect of 5,5-diphenyl-2-thiohydantoin (DPTH) in human vascular endothelial cells.
    Shih CR; Wu J; Liu Y; Liang YC; Lin SY; Sheu MT; Lee WS
    Biochem Pharmacol; 2004 Jan; 67(1):67-75. PubMed ID: 14667929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferation effect of 3-amino-2-imino-3,4-dihydro-2H-1,3-benzothiazin-4-one (BJ-601) on human vascular endothelial cells: G0/G1 p21-associated cell cycle arrest.
    Yu CH; Wu J; Su YF; Ho PY; Liang YC; Sheu MT; Lee WS
    Biochem Pharmacol; 2004 May; 67(10):1907-16. PubMed ID: 15130767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic action of 5,5-diphenyl-2-thiohydantoin-N10 (DPTH-N10).
    Liu Y; Wu J; Ho PY; Chen LC; Chen CT; Liang YC; Cheng CK; Lee WS
    Cancer Lett; 2008 Nov; 271(2):294-305. PubMed ID: 18649995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
    Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
    Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells.
    Wang SW; Pan SL; Guh JH; Chen HL; Huang DM; Chang YL; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Mar; 312(3):917-25. PubMed ID: 15525795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of progesterone-induced antiproliferation in rat aortic smooth muscle cells.
    Lee WS; Liu CW; Juan SH; Liang YC; Ho PY; Lee YH
    Endocrinology; 2003 Jul; 144(7):2785-90. PubMed ID: 12810531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.
    Yu SM; Cheng ZJ; Guh JH; Lee FY; Kuo SC
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):787-92. PubMed ID: 7702575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
    Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
    Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YC-1-induced cyclooxygenase-2 expression is mediated by cGMP-dependent activations of Ras, phosphoinositide-3-OH-kinase, Akt, and nuclear factor-kappaB in human pulmonary epithelial cells.
    Chang MS; Lee WS; Chen BC; Sheu JR; Lin CH
    Mol Pharmacol; 2004 Sep; 66(3):561-71. PubMed ID: 15322248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of extracellular Ca(2+) entry by YC-1, an activator of soluble guanylyl cyclase, through a cyclic GMP-independent pathway in rat neutrophils.
    Wang JP; Chang LC; Huang LJ; Kuo SC
    Biochem Pharmacol; 2001 Sep; 62(6):679-84. PubMed ID: 11551512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models.
    Pan SL; Guh JH; Peng CY; Wang SW; Chang YL; Cheng FC; Chang JH; Kuo SC; Lee FY; Teng CM
    J Pharmacol Exp Ther; 2005 Jul; 314(1):35-42. PubMed ID: 15784655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human vascular endothelial cells proliferation by terbinafine.
    Ho PY; Liang YC; Ho YS; Chen CT; Lee WS
    Int J Cancer; 2004 Aug; 111(1):51-9. PubMed ID: 15185342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ; Chang CY; Lin JK
    Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of superoxide anion generation by YC-1 in rat neutrophils through cyclic GMP-dependent and -independent mechanisms.
    Wang JP; Chang LC; Raung SL; Hsu MF; Huang LJ; Kuo SC
    Biochem Pharmacol; 2002 Feb; 63(4):577-85. PubMed ID: 11992625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.